Patterns of interstitial lung disease and mortality in rheumatoid arthritis

Jorge A. Zamora-Legoff, Megan L. Krause, Cynthia Crowson, Jay H Ryu, Eric Lawrence Matteson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Results.: The study included 181 patients with RA-associated ILD (96% Caucasian; 48% females; 37% never-smokers). The mean age at ILD diagnosis was 67.4 years ( s . d . 9.9). The median time from RA diagnosis to ILD was 4.9 years (range -10.9-48.1). The median follow-up was 3.1 years (range 0.01-14.8). Age, RA disease duration and low initial diffusing capacity for carbon monoxide were predictive of premature mortality in multivariate modelling. Sex, smoking status, obstructive lung disease, seropositivity and erosive disease were not associated with mortality. The 5-year survival rate was 59.7% (95% CI 51.5, 69.2). Survival did not differ between usual interstitial pneumonia, non-specific interstitial pneumonia and organizing pneumonia ( P = 0.42). The GAP model performed well in this cohort for both discrimination and calibration (c-statistic 0.71, standardized incidence ratio 0.97).

Objective.: To characterize a cohort of patients with RA who have interstitial lung disease (ILD) and to assess the utility of previously developed mortality staging systems [gender, age, lung physiology (GAP) and ILD-GAP].

Methods.: All patients with RA and ILD seen at the Mayo Clinic from 1998 to 2014 were identified and manually screened for study inclusion. RA disease characteristics and pulmonary findings including high-resolution CT and pulmonary function testing were evaluated. Survival was estimated using Kaplan-Meier methods. GAP and ILD-GAP models were evaluated using c-statistics and standardized incidence ratios.

Conclusion.: In this large single-centre cohort of patients with RA-ILD, most patients were seropositive and had a history of smoking. ILD most commonly occurred after the RA diagnosis. Mortality was high and did not differ among the types. The GAP model may be useful in assessing mortality risk.

Original languageEnglish (US)
Pages (from-to)344-350
Number of pages7
JournalRheumatology (Oxford, England)
Volume56
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Interstitial Lung Diseases
Rheumatoid Arthritis
Mortality
Lung
Smoking
Obstructive Lung Diseases
Idiopathic Pulmonary Fibrosis
Premature Mortality
Survival
Incidence
Carbon Monoxide
Calibration
Lung Diseases
Pneumonia
Survival Rate

Keywords

  • GAP model
  • ILD-GAP model
  • mortality
  • non-specific interstitial pneumonia
  • organizing pneumonia
  • rheumatoid arthritis
  • usual interstitial pneumonia

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this

Patterns of interstitial lung disease and mortality in rheumatoid arthritis. / Zamora-Legoff, Jorge A.; Krause, Megan L.; Crowson, Cynthia; Ryu, Jay H; Matteson, Eric Lawrence.

In: Rheumatology (Oxford, England), Vol. 56, No. 3, 01.03.2017, p. 344-350.

Research output: Contribution to journalArticle

@article{1ea4ab8b2b92468b8f58d8e969a387a9,
title = "Patterns of interstitial lung disease and mortality in rheumatoid arthritis",
abstract = "Results.: The study included 181 patients with RA-associated ILD (96{\%} Caucasian; 48{\%} females; 37{\%} never-smokers). The mean age at ILD diagnosis was 67.4 years ( s . d . 9.9). The median time from RA diagnosis to ILD was 4.9 years (range -10.9-48.1). The median follow-up was 3.1 years (range 0.01-14.8). Age, RA disease duration and low initial diffusing capacity for carbon monoxide were predictive of premature mortality in multivariate modelling. Sex, smoking status, obstructive lung disease, seropositivity and erosive disease were not associated with mortality. The 5-year survival rate was 59.7{\%} (95{\%} CI 51.5, 69.2). Survival did not differ between usual interstitial pneumonia, non-specific interstitial pneumonia and organizing pneumonia ( P = 0.42). The GAP model performed well in this cohort for both discrimination and calibration (c-statistic 0.71, standardized incidence ratio 0.97).Objective.: To characterize a cohort of patients with RA who have interstitial lung disease (ILD) and to assess the utility of previously developed mortality staging systems [gender, age, lung physiology (GAP) and ILD-GAP].Methods.: All patients with RA and ILD seen at the Mayo Clinic from 1998 to 2014 were identified and manually screened for study inclusion. RA disease characteristics and pulmonary findings including high-resolution CT and pulmonary function testing were evaluated. Survival was estimated using Kaplan-Meier methods. GAP and ILD-GAP models were evaluated using c-statistics and standardized incidence ratios.Conclusion.: In this large single-centre cohort of patients with RA-ILD, most patients were seropositive and had a history of smoking. ILD most commonly occurred after the RA diagnosis. Mortality was high and did not differ among the types. The GAP model may be useful in assessing mortality risk.",
keywords = "GAP model, ILD-GAP model, mortality, non-specific interstitial pneumonia, organizing pneumonia, rheumatoid arthritis, usual interstitial pneumonia",
author = "Zamora-Legoff, {Jorge A.} and Krause, {Megan L.} and Cynthia Crowson and Ryu, {Jay H} and Matteson, {Eric Lawrence}",
year = "2017",
month = "3",
day = "1",
doi = "10.1093/rheumatology/kew391",
language = "English (US)",
volume = "56",
pages = "344--350",
journal = "Rheumatology (United Kingdom)",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Patterns of interstitial lung disease and mortality in rheumatoid arthritis

AU - Zamora-Legoff, Jorge A.

AU - Krause, Megan L.

AU - Crowson, Cynthia

AU - Ryu, Jay H

AU - Matteson, Eric Lawrence

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Results.: The study included 181 patients with RA-associated ILD (96% Caucasian; 48% females; 37% never-smokers). The mean age at ILD diagnosis was 67.4 years ( s . d . 9.9). The median time from RA diagnosis to ILD was 4.9 years (range -10.9-48.1). The median follow-up was 3.1 years (range 0.01-14.8). Age, RA disease duration and low initial diffusing capacity for carbon monoxide were predictive of premature mortality in multivariate modelling. Sex, smoking status, obstructive lung disease, seropositivity and erosive disease were not associated with mortality. The 5-year survival rate was 59.7% (95% CI 51.5, 69.2). Survival did not differ between usual interstitial pneumonia, non-specific interstitial pneumonia and organizing pneumonia ( P = 0.42). The GAP model performed well in this cohort for both discrimination and calibration (c-statistic 0.71, standardized incidence ratio 0.97).Objective.: To characterize a cohort of patients with RA who have interstitial lung disease (ILD) and to assess the utility of previously developed mortality staging systems [gender, age, lung physiology (GAP) and ILD-GAP].Methods.: All patients with RA and ILD seen at the Mayo Clinic from 1998 to 2014 were identified and manually screened for study inclusion. RA disease characteristics and pulmonary findings including high-resolution CT and pulmonary function testing were evaluated. Survival was estimated using Kaplan-Meier methods. GAP and ILD-GAP models were evaluated using c-statistics and standardized incidence ratios.Conclusion.: In this large single-centre cohort of patients with RA-ILD, most patients were seropositive and had a history of smoking. ILD most commonly occurred after the RA diagnosis. Mortality was high and did not differ among the types. The GAP model may be useful in assessing mortality risk.

AB - Results.: The study included 181 patients with RA-associated ILD (96% Caucasian; 48% females; 37% never-smokers). The mean age at ILD diagnosis was 67.4 years ( s . d . 9.9). The median time from RA diagnosis to ILD was 4.9 years (range -10.9-48.1). The median follow-up was 3.1 years (range 0.01-14.8). Age, RA disease duration and low initial diffusing capacity for carbon monoxide were predictive of premature mortality in multivariate modelling. Sex, smoking status, obstructive lung disease, seropositivity and erosive disease were not associated with mortality. The 5-year survival rate was 59.7% (95% CI 51.5, 69.2). Survival did not differ between usual interstitial pneumonia, non-specific interstitial pneumonia and organizing pneumonia ( P = 0.42). The GAP model performed well in this cohort for both discrimination and calibration (c-statistic 0.71, standardized incidence ratio 0.97).Objective.: To characterize a cohort of patients with RA who have interstitial lung disease (ILD) and to assess the utility of previously developed mortality staging systems [gender, age, lung physiology (GAP) and ILD-GAP].Methods.: All patients with RA and ILD seen at the Mayo Clinic from 1998 to 2014 were identified and manually screened for study inclusion. RA disease characteristics and pulmonary findings including high-resolution CT and pulmonary function testing were evaluated. Survival was estimated using Kaplan-Meier methods. GAP and ILD-GAP models were evaluated using c-statistics and standardized incidence ratios.Conclusion.: In this large single-centre cohort of patients with RA-ILD, most patients were seropositive and had a history of smoking. ILD most commonly occurred after the RA diagnosis. Mortality was high and did not differ among the types. The GAP model may be useful in assessing mortality risk.

KW - GAP model

KW - ILD-GAP model

KW - mortality

KW - non-specific interstitial pneumonia

KW - organizing pneumonia

KW - rheumatoid arthritis

KW - usual interstitial pneumonia

UR - http://www.scopus.com/inward/record.url?scp=85021857107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021857107&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kew391

DO - 10.1093/rheumatology/kew391

M3 - Article

C2 - 27940586

AN - SCOPUS:85021857107

VL - 56

SP - 344

EP - 350

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

SN - 1462-0324

IS - 3

ER -